| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/27/1995 | US5428011 Human seminal prostate inhibin in combination with anticancer drug |
| 06/27/1995 | US5428008 Comprising glycoproteins and phospholipids |
| 06/27/1995 | US5428006 Including an n-glycofurol; improves absorption through mucous membranes |
| 06/27/1995 | US5427935 Hybrid membrane bead and process for encapsulating materials in semi-permeable hybrid membranes |
| 06/27/1995 | US5427804 Low-fat edible proteins with maltodextrins and low-saturate oils |
| 06/27/1995 | US5427801 Antifungal agent for the treatment of skin disease caused by trichophyton, eczema or various fungi, and also for activating the recovery of the skin and burns |
| 06/27/1995 | US5427800 Coating absorbent carrier with extract |
| 06/27/1995 | US5427799 Sustained release composition and method utilizing xanthan gum and an active ingredient |
| 06/27/1995 | US5427798 Controlled sustained release tablets containing bupropion |
| 06/27/1995 | US5427796 Growth promoters for animals |
| 06/27/1995 | US5427779 Irradiating a solid polymer and a compound such as substitued indoles, benzofurans, angelicins, coumarins etc; heterogeneous immunoassays; fixing; surface treatment |
| 06/27/1995 | US5427778 Gel formulations containing growth factors and acrylamide polymer |
| 06/27/1995 | US5427767 Particles having crosslinked coatings of natural or synthetic mucopolysaccharides, for contrast in nuclear magnetic resonance imaging |
| 06/27/1995 | US5426942 Method and apparatus for driving microbodies |
| 06/27/1995 | CA2022956C Agglomerated psyllium husk containing edible acid |
| 06/27/1995 | CA1336071C Pharmaceutical composition for systemic transdermal administration |
| 06/27/1995 | CA1336070C Controlled release dosage form comprising different cellulose ethers |
| 06/27/1995 | CA1336069C Chewable medicament tablet containing means for taste masking |
| 06/27/1995 | CA1336068C Multiwall polymeric microcapsules |
| 06/27/1995 | CA1336067C Preparation of sized populations of liposomes |
| 06/24/1995 | CA2138909A1 Solid insecticidal formulation |
| 06/22/1995 | WO1995016702A1 Peptide inhibitors of cxc intercrine molecules |
| 06/22/1995 | WO1995016511A1 Deep-bed filter for exterminating micro-organisms and inactivating viruses and its use |
| 06/22/1995 | WO1995016465A1 Pharmaceutical compositions containing alkyl polyoxyalkylene carboxylates |
| 06/22/1995 | WO1995016464A1 Controlled release of pharmaceutically active substances for immunotherapy |
| 06/22/1995 | WO1995016460A1 Composition containing soluble thrombomodulins |
| 06/22/1995 | WO1995016452A2 Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems |
| 06/22/1995 | WO1995016451A1 Tablets for the controlled release of 4-asa |
| 06/22/1995 | WO1995016448A1 Paroxetine tablets and process to prepare them |
| 06/22/1995 | WO1995016446A1 Ranitidine compositions |
| 06/22/1995 | WO1995016445A1 Pharmaceutical compositions for topical use containing (s)-2-(4-isobutylphenyl)propionic acid |
| 06/22/1995 | WO1995016441A1 Ultramicroemulsions from spontaneously dispersible concentrates with pharmacologically effective esters of apocarotinols |
| 06/22/1995 | WO1995016440A1 Percutaneous administration patch medicine |
| 06/22/1995 | WO1995016439A1 Adhesive patch for transdermal drug delivery |
| 06/22/1995 | WO1995016438A1 Biphasic capsule formulation |
| 06/22/1995 | WO1995016437A1 Method of transmitting a biologically active material to a cell |
| 06/22/1995 | WO1995016436A1 Lipid vesicles containing avocado oil unsaponifiables |
| 06/22/1995 | WO1995016435A2 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent |
| 06/22/1995 | WO1995016434A1 Sucrose ester c-20 to c-28 alcohol formulations |
| 06/22/1995 | WO1995016433A1 Novel foaming compositions, particularly for rectal foams, and resulting foams |
| 06/22/1995 | WO1995009611A3 Stable protein: phospholipid compositions and methods |
| 06/22/1995 | DE4407742C1 Transdermal patch for treating tumours |
| 06/22/1995 | DE4406332C1 Use of transdermal glyceryl tri:nitrate formulations in pregnancy |
| 06/22/1995 | CA2274387A1 Paroxetine tablets and process to prepare them |
| 06/22/1995 | CA2179178A1 Adhesive patch for transdermal drug delivery |
| 06/22/1995 | CA2179147A1 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent |
| 06/22/1995 | CA2178902A1 Controlled release of pharmaceutically active substances for immunotherapy |
| 06/22/1995 | CA2174729A1 A method of preventing depletion of non-autologous hematopoietic cells and animal model systems for use thereof |
| 06/21/1995 | EP0658629A1 Process for preparation of polyol fatty acid ester and glyceride mixture obtained |
| 06/21/1995 | EP0658348A2 Aqueous solution inclusion complexes of benzothiophene compounds with cyclodextrins |
| 06/21/1995 | EP0658347A2 Pharmaceutical composition, containing diclofenac and 2-hydroxypropyl-beta-cyclodextrin |
| 06/21/1995 | EP0658344A1 Liposome preparation containing tricyclic compound |
| 06/21/1995 | EP0658116A1 Methods useful in endotoxin prophylaxis and therapy |
| 06/21/1995 | EP0658111A1 Methods for enhancing drug delivery with modified saponins |
| 06/21/1995 | EP0658108A1 X-hydroxy saturated fatty acids for the treatment of corns and calluses |
| 06/21/1995 | EP0658106A1 Thiol derivates for maintaining and/or increasing muscle strength and body cell mass |
| 06/21/1995 | EP0658105A1 Local drug delivery film for periodontal treatment |
| 06/21/1995 | EP0658104A1 Divisible oblong tablet. |
| 06/21/1995 | EP0658102A1 Novel pharmaceutical peptide preparations for general delivery |
| 06/21/1995 | EP0658101A1 Surfactant free aerosol formulations containing beclomethasone dipropionate |
| 06/21/1995 | EP0550704B1 Biotenside esters with vitamin d compounds; their preparation and transformation into spontaneously dispersible concentrates, and their use for treating tumors |
| 06/21/1995 | EP0540547B1 Prophylactic and therapeutic applications of peroxidases |
| 06/21/1995 | EP0538442B1 Method for improving the therapeutic efficiency of liposoluble antifungal agents from the imidazole family, and composition for implementing same |
| 06/21/1995 | EP0411105B1 Bone collagen matrix for implants |
| 06/21/1995 | CN1103794A Medicinal sprinkling agent for treatment of acute soft tissue injury |
| 06/21/1995 | CN1103792A Proprietary Chinese medicine for curing stomach disease and the prepn. method |
| 06/21/1995 | CN1103789A Multi-function vagina suppository |
| 06/21/1995 | CN1028963C Concentrated stabilized microbubble-type ultrasonic imaging agent |
| 06/21/1995 | CN1028962C Stabilization medicines, process for producing them and slabilization pharmaceutical composition |
| 06/21/1995 | CN1028961C Pharmaceutical solution |
| 06/20/1995 | US5426248 Stable vitamin A |
| 06/20/1995 | US5426163 Redispersible powder composed of n-vinylpyrrolidone/vinyl acetate copolymer the preparation and use thereof |
| 06/20/1995 | US5425993 Preparing lipid phase, contacting with aqueous phase to be encapsulated in vesicles, adding dispersion aqueous phase and precursor of submicronic particles, adding solution of agent capable of transforming precursor into particles |
| 06/20/1995 | US5425955 Compositions of insoluble film-forming polymers and uses therefor |
| 06/20/1995 | US5425953 Sustained release film forming liquid containing water soluble cellulosic polymer, peroxy compound, soluble stabilizer, vehicle; storage stability |
| 06/20/1995 | US5425950 Antiserotonine agent |
| 06/20/1995 | US5425945 Agglomerated psyllium husk containing edible acid |
| 06/20/1995 | US5425943 Modified tPA-containing injection composition having increased solubility |
| 06/20/1995 | US5425935 Metallic radionuclide labelled 4-quinolone antibiotic for gamma ray scintigraphy diagnostic imaging |
| 06/20/1995 | CA2042583C Foamable aerosol preparation |
| 06/20/1995 | CA1336034C Biodegradable polypeptide and the use thereof for the gradual release of drugs |
| 06/20/1995 | CA1336003C Pentamidine salts useful in the treatment and prophylaxis of pneumocystis carinii pneumonia |
| 06/16/1995 | CA2137897A1 Biaromatic compounds derived from amides; pharmaceutical and cosmetic compositions containing the same and their uses |
| 06/16/1995 | CA2137119A1 Non-reducing oligosaccharide with neotrehalose structure, and its production and uses |
| 06/15/1995 | WO1995015767A1 Long-acting injection suspensions and a process for their preparation |
| 06/15/1995 | WO1995015762A1 Liposomal formulations containing vidarabine or its derivatives |
| 06/15/1995 | WO1995015761A1 Homeopathic solutions containing a nucleic acid |
| 06/15/1995 | WO1995015755A1 Transdermal therapeutical system for preventing poisoning by organophosphoric nurotoxins that consists of a combination of active substances including a parasympathomimetic and a parasympatholytic agent |
| 06/15/1995 | WO1995015754A1 Transdermal delivery device |
| 06/15/1995 | WO1995015751A1 Combined antipyretic analgesic drug |
| 06/15/1995 | WO1995015748A1 Microsphere drug delivery system |
| 06/15/1995 | WO1995015747A1 Local delivery of fibrinolysis enhancing agents |
| 06/15/1995 | WO1995015746A1 Liposome delivery systems |
| 06/15/1995 | WO1995015740A1 Optionally crosslinkable coatings, compositions and methods of use |
| 06/15/1995 | CA2178620A1 Microsphere drug delivery system |
| 06/15/1995 | CA2178486A1 Dental compositions comprising silicone-grafted polymers |
| 06/15/1995 | CA2178100A1 Homeopathic solutions containing a nucleic acid |
| 06/15/1995 | CA2177588A1 Transdermal delivery device containing (s)-3methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole |
| 06/15/1995 | CA2137533A1 Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof |
| 06/14/1995 | EP0657465A2 Liponucleotide compounds |